Back

Acute and long-term success of left atrial anterior line and mitral isthmus line ablation in patients after mitral valve surgery

29 August 2022 (14:40 - 14:50)
Organised by:
Congress Presentation Part of: Innovations in supraventricular tachycardia management Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Christine Lemes

Ordensklinikum Linz Elisabethinen, Linz (Austria)

4 More presentations in this session

Presentation thumbnail
Higher risk of adverse outcomes and need for pacemaker among patients undergoing radiofrequency ablation due to ectopic atrial tachycardia - a Nationwide registry-based Danish study
Miss C. Middelfart (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Catheter ablation of atrial arrhythmias by using a multipolar grid-patterned high density mapping catheter in patients with congenital heart disease: a single-center experience
Professor G. Kerst (Stuttgart, DE)
Abstract Slides Video
Presentation thumbnail
Electrophysiological characteristics and catheter ablation of atypical fast-slow atrioventricular nodal reentrant tachycardia using an inferolateral left atrial slow pathway
Associate Professor Y. Kaneko (Maebashi, JP)
Abstract Slides Video
Presentation thumbnail
Utility of open window mapping using high-density mapping approach in accessory pathways ablation
Doctor L. Gonzalez-Melchor (Arrecife, Las Palmas, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Innovations in supraventricular tachycardia management

The Event

Event poster

ESC Congress 2022

29 August 2022 14:40 CET
You may be interested in
thumbnail
Congress Presentation
Assessment of intraoperative radiofrequency pulmonary veins isolation for treatment of chronic atrial fibrillation in patient's undergoing rheumatic mitral valve replacement
thumbnail
Congress Presentation
Linear ablation at the mitral isthmus following mitral valve surgery
thumbnail
Congress Presentation
Early reverse remodeling of the mitral valve apparatus following atrial fibrillation ablation: insights from a prospective echocardiographic study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources